Minimizing risk in a global economy is becoming increasing difficult. Due to the globalization of business, more and more companies interact with a variety of legal regimes and face potential enforcement actions from a multitude of agencies and governments. This, combined with the extra-territorial reach of some U.S. laws, such as the antitrust statutes, export control laws, Foreign Corrupt Practices Act, Sarbanes-Oxley, and the PATRIOT Act, should cause all companies to ensure they have effective compliance programs to minimize legal exposure. This program provides cutting-edge and practical advice on how to minimize legal risk in a global economy by discussing key components of a global compliance program and the challenges to instilling compliance in various jurisdictions. Our panelists will also discuss how to encourage internal reporting, create an effective hotline program, manage whistle blowers, and protect confidential communications between counsel and clients in a world of differing privilege protections."
Mr. David R. Brinley served as Vice President, General Counsel and Director of Shell Canada Ltd., and also served as its Secretary.
Maria Pasquale is Celgene Corporation Corporate Vice President Legal and Chief Counsel.
When she started with Celgene Corporation in 2001, it was a small biopharmaceutical company with offices in New Jersey and California. Today, Celgene is a multinational corporation with headquarters in New Jersey and Switzerland, with other offices spanning the globe from Paris to Tokyo. Just two years ago, Celgene became an S&P 500 company.
Prior to joining Celgene, Pasquale was a patent attorney at Pennie & Edmonds LLP in New York (now part of Jones Day). It was her first job out of law school, and she stayed on for over ten years. Before that, Pasquale (who holds a biochemistry degree from SUNY Stony Brook) spent five years performing cancer and genetic research at laboratories in and near New York City.
Fiona A. Schaeffer
Fiona Schaeffer has extensive experience in antitrust counseling, litigation, and transactional matters for clients in a broad range of industries, with particular depth of experience in the health care, financial services, and media sectors. She advises corporate and private equity clients on antitrust aspects of mergers and acquisitions, joint ventures, distribution arrangements, licensing agreements, and other commercial transactions. She frequently serves as global coordinating antitrust counsel for transactions requiring antitrust review in the U.S., EU, and other jurisdictions worldwide. She also represents clients in government investigations, arbitrations, and litigations, including multidistrict treble damages class actions and private antitrust suits in federal and state courts.
Fiona practiced for a number of years in Europe, representing clients in cross-border transactions and EU litigation. She has appeared before the European courts in Luxembourg and worked on complex antitrust proceedings in the UK High Court.
According to clients in the Chambers USA 2010 directory, she is "an outside counsel who would be extremely difficult to replicate â€” she is a trusted adviser who understands our business as well as our in-house lawyers."
Prior to joining Jones Day in 2010, Fiona successfully completed many M&A transactions, including Houghton Mifflin's acquisition of the Harcourt Education business of Reed Elsevier Group and UnitedHealth Group's acquisition of PacifiCare Health System. She also represented one of the leading U.S. private equity firms in a putative nationwide antitrust class action and a global payment network company in a multidistrict federal and state class action lawsuit regarding currency conversion fees.
Fiona is active in the antitrust law sections of the ABA and New York State Bar Association.
Charles Scudder is the Assistant General Counsel and Corporate Security at Akzo Nobel Inc.
Joseph A. Vicario, Jr. is Senior Counsel of International Trade Regulation at Texas Instruments, Inc.